General paperInhibition of ferrous-induced lipid peroxidation by dipyridamole, RA-642 and mopidamol (cas 13665-88-8) in human lung tissue

Add time:09/07/2019    Source:sciencedirect.com

1.1. The in vitro production of ferrous-induced lipid peroxidation was 5.71 times higher in rat lung tissue than in human lung membranes.2.2. The pyrimido-pyrimidine derivative RA-642 shows a more potent inhibition of ferrous-induced lipid peroxidation than dipyridamole; mopidamol (cas 13665-88-8) had no effect. All the compounds showed higher anti-peroxidative effect in rat than in human lung tissue.

We also recommend Trading Suppliers and Manufacturers of mopidamol (cas 13665-88-8). Pls Click Website Link as below: cas 13665-88-8 suppliers

Prev:PaperThe pyrimido-pyrimidine derivatives, dipyridamole, mopidamol (cas 13665-88-8) and RA-642, prevent from retinal vascular defects in experimental diabetes mellitus
Next:Differential effects of the pyrimido-pyrimidine derivatives, dipyridamole and mopidamol (cas 13665-88-8), on platelet and vascular cyclooxygenase activity)